News & Articles

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research

The test operates using the company’s fully automated Lumipulse G1200 instrument system

Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts

By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable

Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform

Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale

The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers

The first cleared troponin assay in the U.S. for longer-term prognostic insights

Experts from Chan Zuckerberg Initiative, FDA, AbbVie, Elsevier, Penn Medicine, Takeda and others discuss patient-centricity, data standards, and copyright

Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions

Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s

Roche obtains CE certification for VENTANA CLDN18 (43-14A) RxDx Assay to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

Find out how CLINICAL24 Ambassador, Dr. Frank Peacock, is advancing cardiovascular care through clinical trials in acute coronary syndrome and heart failure, driving progress in emergency medicine

Research collaboration agreement will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures

Pilot study suggests that the test could detect early stages of the disease before clinical symptoms appear

Collaboration is a step forward in non-invasive colorectal cancer early detection

From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market

Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department